YOLFTbeta
Aptamer Group PLC

Aptamer Group PLC

APTA · LSE · Healthcare / Biotechnology

0.365GBX-0.01 (-2.67%)

Price History

Full chart

Market Stats

Previous Close0.375
Open0.375
Day Range0.3356 – 0.40
52-Week Range0.30 – 1.25
Volume15.62M
Market Cap11.27M
P/E (TTM)0.00
Forward P/E0.00
EPS0.00
Dividend Yield0.00%
Beta0.87
50-Day Avg0.3791
200-Day Avg0.6214

About

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Arron Craig Tolley
  • Employees30
  • HeadquartersWindmill House, York, United Kingdom, YO10 5BR, UK
  • Websitehttps://aptamergroup.com

Leadership

  • Dr. Arron Craig TolleyCEO, Co-Founder & Director · b. 1977
  • Mr. Andrew Mark RapsonCFO, Company Secretary & Director · b. 1981
  • Dr. David BunkaChief Scientific Officer & Executive Director · b. 1978

Financials

Income Statement

Currency: GBP2019-03-312020-03-312021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue986.66K854.57K1.28M4.04M1.75M860.00K1.20M
Growth (%)--13.39%+49.78%+215.31%-56.59%-50.91%+39.88%
Cost of Revenue373.81K398.60K741.60K1.35M1.39M610.00K853.00K
Gross Profit612.85K455.97K538.40K2.69M359.00K250.00K350.00K
Gross Margin62.11%53.36%42.06%66.53%20.49%29.07%29.09%
Operating Expense1.15M1.38M2.84M5.26M8.52M3.33M3.05M
Operating Income-540.24K-922.05K-2.30M-2.58M-8.16M-3.08M-2.70M
Operating Margin-54.75%-107.90%-179.50%-63.83%-465.58%-358.60%-224.19%
EBITDA-425.25K-733.59K-2.24M-2.19M-7.36M-2.81M-2.28M
EBITDA Margin-43.10%-85.84%-174.81%-54.39%-420.32%-327.33%-189.86%
Net Income-454.98K-674.73K-1.85M-2.09M-7.84M-2.96M-2.42M
Net Income Margin-46.11%-78.96%-144.50%-51.86%-447.26%-343.95%-201.50%
R&D63.08K170.46K491.20K848.00K474.00K317.00K305.00K
R&D as % of Total Revenue6.39%19.95%38.38%21.01%27.05%36.86%25.35%
Interest Expense7.44K13.22K28.80K46.00K134.00K81.00K57.00K
Interest Expense % of Total Revenue0.75%1.55%2.25%1.14%7.65%9.42%4.74%

Balance Sheet

Currency: GBP2019-03-312020-03-312021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets1.40M1.39M2.06M11.52M2.75M2.77M2.83M
Total Liabilities497.25K1.14M1.96M3.47M2.45M1.88M1.45M
Total Equity899.87K245.81K105.00K8.05M304.00K887.00K1.38M
Cash727.16K293.15K369.00K6.69M234.00K870.00K1.06M
Total Debt71.57K160.98K78.00K1.31M1.08M817.00K491.00K
Net Debt-655.59K-132.17K-291.00K-5.38M-165.00K-53.00K-568.00K

Cash Flow

Currency: GBP2019-03-312020-03-312021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow-844.93K-82.71K-1.10M-2.38M-4.06M-2.28M-2.00M
Investing Cash Flow-40.77K-160.79K-339.20K-418.00K-2.03M-122.00K-92.00K
Financing Cash Flow1.41M-190.51K1.50M9.12M-365.00K3.04M2.28M
Capital Expenditure40.82K160.83K157.60K418.00K2.03M122.00K10.00K
Free Cash Flow-885.75K-243.54K-1.26M-2.79M-6.09M-2.41M-2.01M
FCF to OCF104.83%294.44%114.34%117.60%149.90%105.34%100.50%

Earnings

Report DateMar 31, 2022Oct 18, 2022Mar 14, 2023Mar 11, 2025
EPS Estimate0.000.000.000.00
EPS Actual-0.02-0.01-0.040.00
Surprise----
Timing----

Key Statistics & Ratios

Market Cap11.27M
Enterprise Value10.08M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.18
Price / Book5.00
EPS0.00
Book Value0.001
Revenue (TTM)1.38M
Gross Profit (TTM)672.00K
EBITDA-2.44M
Profit Margin-178.52%
Operating Margin-149.52%
Return on Equity-102.18%
Return on Assets-40.16%
Shares Outstanding3.47B
Shares Float2.17B
Beta0.87
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%